Protective Effect of Salvianolic Acid A against N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Yumei Zhou, Weiwei Xu, Anqi Liu, Ye Tao, Qun Wang, Yanfeng Yang, Liqiang Wang, Yifei HuangEvidence-based 2022 · DOI

TL;DR

This study investigates the protective effects of Salvianolic Acid A (Sal A) against N-methyl-N-nitrosourea (MNU)-induced retinal degeneration in mice. Sal A demonstrated significant protective capabilities by mitigating oxidative stress and apoptosis in photoreceptor cells, suggesting its potential as a therapeutic agent for retinal diseases.

What Problem Does This Paper Address?

Retinal degeneration (RD) is a severe, irreversible condition leading to vision loss, characterized by photoreceptor cell oxidation and apoptosis. Current treatments are limited, making the search for safe and effective antioxidant therapies a critical research area. This paper addresses the need for such therapies by exploring the potential of Sal A, a compound known for its antioxidant properties, to prevent or reverse MNU-induced RD. MNU is a chemical agent commonly used to create animal models of RD by inducing oxidative stress and photoreceptor cell death.

Methods

The researchers employed a multi-faceted approach using both in vivo and in vitro models.

  • Animal Model: Male C57BL/6 mice were induced with retinal degeneration using a single intraperitoneal injection of N-methyl-N-nitrosourea (MNU).
  • Treatment: Mice were treated with varying doses of Salvianolic Acid A (Sal A) via intravenous injection. Control groups received either vehicle or Sal A alone.
  • Functional Assessment: Electroretinography (ERG) was performed to assess the electrical activity of the retina, measuring b-wave amplitudes under scotopic and photopic conditions.
  • Morphological Assessment: Histopathological examination of retinal sections was conducted to measure the thickness of the outer nuclear layer (ONL), a key indicator of photoreceptor health.
  • Biochemical Analysis: Superoxide dismutase (SOD) activity and malondialdehyde (MDA) content were measured in retinal tissues to assess oxidative stress levels. SOD is an antioxidant enzyme, while MDA is a marker of lipid peroxidation.
  • Molecular Analysis: Western blotting and RT-PCR were used to quantify the expression levels of apoptosis-related genes, specifically Bax (pro-apoptotic), Bcl-2 (anti-apoptotic), and caspase-3 (a key executioner caspase in apoptosis).
  • In Vitro Model: A mouse retinal photoreceptor cone cell line (661 W) was treated with MNU and Sal A to evaluate the direct protective effects of Sal A on cellular integrity and viability. Cell viability was assessed using the MTT assay.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Sal A as a Potent Protector: Sal A effectively counteracted the damage caused by MNU, demonstrating a dose-dependent protective effect. This suggests Sal A can be a valuable tool in managing RD.
  • Dual Mechanism of Action: The protective effect of Sal A appears to stem from a combination of antioxidant and antiapoptotic activities, addressing the two primary pathological processes in MNU-induced RD.
  • Restoration of Retinal Function: Sal A treatment not only preserved the structural integrity of the retina (ONL thickness) but also significantly improved retinal electrical activity as measured by ERG.
  • Modulation of Oxidative Stress Markers: Sal A treatment led to increased SOD activity and decreased MDA levels, directly indicating its ability to combat oxidative stress.
  • Apoptosis Pathway Regulation: Sal A influenced the expression of key apoptotic genes, increasing the anti-apoptotic Bcl-2 and decreasing the pro-apoptotic Bax and caspase-3, thereby inhibiting the apoptotic cascade.
  • In Vitro Validation: The in vitro experiments with 661 W cells corroborated the in vivo findings, showing that Sal A protects photoreceptor cells from MNU-induced damage and preserves cell viability.

Key Results

  • ERG Improvement: Sal A treatment significantly improved b-wave amplitudes in ERGs of MNU-treated mice, with higher doses showing greater efficacy.
  • ONL Thickness Preservation: Sal A treatment prevented the significant thinning of the ONL layer observed in MNU-treated mice, with the higher dose of Sal A showing a more pronounced effect.
  • Biochemical Markers: Sal A treatment increased SOD activity and decreased MDA levels in retinal tissues on both day 3 and day 7 post-MNU induction.
  • Gene Expression: On day 3, Sal A treatment significantly reduced the elevated levels of Bax and caspase-3 mRNA and protein in MNU-treated mice, while increasing Bcl-2 expression. These effects were more pronounced with the higher dose of Sal A.
  • Cell Viability: In the in vitro study, MNU significantly reduced 661 W cell viability, while Sal A treatment significantly attenuated this reduction.

Limitations and Future Work

  • Specific Mechanisms: While the study identifies antioxidant and antiapoptotic mechanisms, further detailed investigation into the precise molecular pathways targeted by Sal A could be beneficial.
  • Long-Term Effects: The study primarily focused on effects up to day 7. Investigating the long-term efficacy and safety of Sal A in preventing or reversing RD would be valuable.
  • Clinical Translation: The findings are based on animal models. Future research should focus on translating these promising results into clinical trials for human patients with retinal degeneration.
  • Combination Therapies: Exploring the potential synergistic effects of Sal A with other existing or experimental RD treatments could lead to more robust therapeutic strategies.

Summary updated

Abstract

Sal A alleviates the damage caused by MNU to retinal photoreceptor cells <i>in vivo</i> and <i>in vivo</i>, and its protective effect is related to its antioxidant and antiapoptotic activities.
BibTeX
@inproceedings{zhou2022protective,
  author = {Yumei Zhou and Weiwei Xu and Anqi Liu and Ye Tao and Qun Wang and Yanfeng Yang and Liqiang Wang and Yifei Huang},
  title = {{Protective Effect of Salvianolic Acid A against N-Methyl-N-Nitrosourea-Induced Retinal Degeneration}},
  booktitle = {Evidence-based},
  year = {2022},
  doi = {10.1155/2022/1219789},
}
Figure